Mark van Eldijk, business unit director Nanomedicines at Ardena, explores how flow manufacturing can help reshape the production of nanomedicines and offer a scalable and reproducible path from innovation to implementation.
AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union (EU) for subcutaneous self-administration as a pre-filled pen for adult patients with systemic lupus erythematosus (SLE) on top of standard therapy.
Craig Sommerville, senior vice president of the MDI Business Unit at Kindeva, discusses the drivers behind the industry-wide shift to NGPs with low global warming potential (GWP).
Phillips Medisize, a Molex company, will showcase its inhaled drug delivery device and formulation platforms and capabilities at the Drug Delivery to the Lungs conference (DDL 2025) in Edinburgh, Scotland, 10-12th December.
Olivia Friett, editor of European Pharmaceutical Manufacturer spoke to Markus Laubscher, head of pharma at Orbia Fluor & Energy Materials for the 30th anniversary of Zephex.
Antares Vision Group, a technological partner in the digitalisation of products and supply chains for companies and institutions, demonstrated its set of equipment solutions for prefilled syringe processing at Pack Expo Las Vegas.
Jennifer Green, senior global technical business development manager at Lubrizol explores importance of device design, as diabetes management is rapidly advancing, and the choice of materials is what helps distinguish good design.
David O’Connell, director of scientific affairs at PCI Pharma Services, explores how enabling technologies are helping targeted protein degraders (TPDs) overcome their biggest challenge.
